Global Solid-phase Oligonucleotide Synthesis Supply, Demand and Key Producers, 2024-2030

Page: 114

Published Date: 10 Feb 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Solid-phase Oligonucleotide Synthesis market size is expected to reach $ 1230 million by 2030, rising at a market growth of 16.1% CAGR during the forecast period (2024-2030).

This report studies the global Solid-phase Oligonucleotide Synthesis demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Solid-phase Oligonucleotide Synthesis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Solid-phase Oligonucleotide Synthesis that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Solid-phase Oligonucleotide Synthesis total market, 2019-2030, (USD Million)
Global Solid-phase Oligonucleotide Synthesis total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Solid-phase Oligonucleotide Synthesis total market, key domestic companies and share, (USD Million)
Global Solid-phase Oligonucleotide Synthesis revenue by player and market share 2019-2024, (USD Million)
Global Solid-phase Oligonucleotide Synthesis total market by Type, CAGR, 2019-2030, (USD Million)
Global Solid-phase Oligonucleotide Synthesis total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Solid-phase Oligonucleotide Synthesis market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Genescript, GeneArt (Thermofischer), Renesas Electronics Corporation, DNA 2.0 (ATUM), OriGene, BBI, Genewiz, Eurofins Genomics and Gene Oracle, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Solid-phase Oligonucleotide Synthesis market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Solid-phase Oligonucleotide Synthesis Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Solid-phase Oligonucleotide Synthesis Market, Segmentation by Type
    Primers
    Probes
    Intermediate-scale Synthesis Oligos
    Large-scale Synthesis Oligos
    Linkers and Adaptors

Global Solid-phase Oligonucleotide Synthesis Market, Segmentation by Application
    Commercial
    Academic Research

Companies Profiled:
    Genescript
    GeneArt (Thermofischer)
    Renesas Electronics Corporation
    DNA 2.0 (ATUM)
    OriGene
    BBI
    Genewiz
    Eurofins Genomics
    Gene Oracle
    SBS Genetech
    Bio Basic

Key Questions Answered
1. How big is the global Solid-phase Oligonucleotide Synthesis market?
2. What is the demand of the global Solid-phase Oligonucleotide Synthesis market?
3. What is the year over year growth of the global Solid-phase Oligonucleotide Synthesis market?
4. What is the total value of the global Solid-phase Oligonucleotide Synthesis market?
5. Who are the major players in the global Solid-phase Oligonucleotide Synthesis market?

Table of Contents

1 Supply Summary
    1.1 Solid-phase Oligonucleotide Synthesis Introduction
    1.2 World Solid-phase Oligonucleotide Synthesis Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Solid-phase Oligonucleotide Synthesis Total Market by Region (by Headquarter Location)
        1.3.1 World Solid-phase Oligonucleotide Synthesis Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Solid-phase Oligonucleotide Synthesis Market Size (2019-2030)
        1.3.3 China Solid-phase Oligonucleotide Synthesis Market Size (2019-2030)
        1.3.4 Europe Solid-phase Oligonucleotide Synthesis Market Size (2019-2030)
        1.3.5 Japan Solid-phase Oligonucleotide Synthesis Market Size (2019-2030)
        1.3.6 South Korea Solid-phase Oligonucleotide Synthesis Market Size (2019-2030)
        1.3.7 ASEAN Solid-phase Oligonucleotide Synthesis Market Size (2019-2030)
        1.3.8 India Solid-phase Oligonucleotide Synthesis Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Solid-phase Oligonucleotide Synthesis Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Solid-phase Oligonucleotide Synthesis Major Market Trends

2 Demand Summary
    2.1 World Solid-phase Oligonucleotide Synthesis Consumption Value (2019-2030)
    2.2 World Solid-phase Oligonucleotide Synthesis Consumption Value by Region
        2.2.1 World Solid-phase Oligonucleotide Synthesis Consumption Value by Region (2019-2024)
        2.2.2 World Solid-phase Oligonucleotide Synthesis Consumption Value Forecast by Region (2025-2030)
    2.3 United States Solid-phase Oligonucleotide Synthesis Consumption Value (2019-2030)
    2.4 China Solid-phase Oligonucleotide Synthesis Consumption Value (2019-2030)
    2.5 Europe Solid-phase Oligonucleotide Synthesis Consumption Value (2019-2030)
    2.6 Japan Solid-phase Oligonucleotide Synthesis Consumption Value (2019-2030)
    2.7 South Korea Solid-phase Oligonucleotide Synthesis Consumption Value (2019-2030)
    2.8 ASEAN Solid-phase Oligonucleotide Synthesis Consumption Value (2019-2030)
    2.9 India Solid-phase Oligonucleotide Synthesis Consumption Value (2019-2030)

3 World Solid-phase Oligonucleotide Synthesis Companies Competitive Analysis
    3.1 World Solid-phase Oligonucleotide Synthesis Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Solid-phase Oligonucleotide Synthesis Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Solid-phase Oligonucleotide Synthesis in 2023
        3.2.3 Global Concentration Ratios (CR8) for Solid-phase Oligonucleotide Synthesis in 2023
    3.3 Solid-phase Oligonucleotide Synthesis Company Evaluation Quadrant
    3.4 Solid-phase Oligonucleotide Synthesis Market: Overall Company Footprint Analysis
        3.4.1 Solid-phase Oligonucleotide Synthesis Market: Region Footprint
        3.4.2 Solid-phase Oligonucleotide Synthesis Market: Company Product Type Footprint
        3.4.3 Solid-phase Oligonucleotide Synthesis Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Solid-phase Oligonucleotide Synthesis Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Solid-phase Oligonucleotide Synthesis Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Solid-phase Oligonucleotide Synthesis Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Solid-phase Oligonucleotide Synthesis Consumption Value Comparison
        4.2.1 United States VS China: Solid-phase Oligonucleotide Synthesis Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Solid-phase Oligonucleotide Synthesis Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Solid-phase Oligonucleotide Synthesis Companies and Market Share, 2019-2024
        4.3.1 United States Based Solid-phase Oligonucleotide Synthesis Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Solid-phase Oligonucleotide Synthesis Revenue, (2019-2024)
    4.4 China Based Companies Solid-phase Oligonucleotide Synthesis Revenue and Market Share, 2019-2024
        4.4.1 China Based Solid-phase Oligonucleotide Synthesis Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Solid-phase Oligonucleotide Synthesis Revenue, (2019-2024)
    4.5 Rest of World Based Solid-phase Oligonucleotide Synthesis Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Solid-phase Oligonucleotide Synthesis Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Solid-phase Oligonucleotide Synthesis Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Solid-phase Oligonucleotide Synthesis Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Primers
        5.2.2 Probes
        5.2.3 Intermediate-scale Synthesis Oligos
        5.2.4 Large-scale Synthesis Oligos
        5.2.5 Linkers and Adaptors
    5.3 Market Segment by Type
        5.3.1 World Solid-phase Oligonucleotide Synthesis Market Size by Type (2019-2024)
        5.3.2 World Solid-phase Oligonucleotide Synthesis Market Size by Type (2025-2030)
        5.3.3 World Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Solid-phase Oligonucleotide Synthesis Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Commercial
        6.2.2 Academic Research
    6.3 Market Segment by Application
        6.3.1 World Solid-phase Oligonucleotide Synthesis Market Size by Application (2019-2024)
        6.3.2 World Solid-phase Oligonucleotide Synthesis Market Size by Application (2025-2030)
        6.3.3 World Solid-phase Oligonucleotide Synthesis Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Genescript
        7.1.1 Genescript Details
        7.1.2 Genescript Major Business
        7.1.3 Genescript Solid-phase Oligonucleotide Synthesis Product and Services
        7.1.4 Genescript Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Genescript Recent Developments/Updates
        7.1.6 Genescript Competitive Strengths & Weaknesses
    7.2 GeneArt (Thermofischer)
        7.2.1 GeneArt (Thermofischer) Details
        7.2.2 GeneArt (Thermofischer) Major Business
        7.2.3 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product and Services
        7.2.4 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 GeneArt (Thermofischer) Recent Developments/Updates
        7.2.6 GeneArt (Thermofischer) Competitive Strengths & Weaknesses
    7.3 Renesas Electronics Corporation
        7.3.1 Renesas Electronics Corporation Details
        7.3.2 Renesas Electronics Corporation Major Business
        7.3.3 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product and Services
        7.3.4 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Renesas Electronics Corporation Recent Developments/Updates
        7.3.6 Renesas Electronics Corporation Competitive Strengths & Weaknesses
    7.4 DNA 2.0 (ATUM)
        7.4.1 DNA 2.0 (ATUM) Details
        7.4.2 DNA 2.0 (ATUM) Major Business
        7.4.3 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product and Services
        7.4.4 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 DNA 2.0 (ATUM) Recent Developments/Updates
        7.4.6 DNA 2.0 (ATUM) Competitive Strengths & Weaknesses
    7.5 OriGene
        7.5.1 OriGene Details
        7.5.2 OriGene Major Business
        7.5.3 OriGene Solid-phase Oligonucleotide Synthesis Product and Services
        7.5.4 OriGene Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 OriGene Recent Developments/Updates
        7.5.6 OriGene Competitive Strengths & Weaknesses
    7.6 BBI
        7.6.1 BBI Details
        7.6.2 BBI Major Business
        7.6.3 BBI Solid-phase Oligonucleotide Synthesis Product and Services
        7.6.4 BBI Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 BBI Recent Developments/Updates
        7.6.6 BBI Competitive Strengths & Weaknesses
    7.7 Genewiz
        7.7.1 Genewiz Details
        7.7.2 Genewiz Major Business
        7.7.3 Genewiz Solid-phase Oligonucleotide Synthesis Product and Services
        7.7.4 Genewiz Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Genewiz Recent Developments/Updates
        7.7.6 Genewiz Competitive Strengths & Weaknesses
    7.8 Eurofins Genomics
        7.8.1 Eurofins Genomics Details
        7.8.2 Eurofins Genomics Major Business
        7.8.3 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product and Services
        7.8.4 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Eurofins Genomics Recent Developments/Updates
        7.8.6 Eurofins Genomics Competitive Strengths & Weaknesses
    7.9 Gene Oracle
        7.9.1 Gene Oracle Details
        7.9.2 Gene Oracle Major Business
        7.9.3 Gene Oracle Solid-phase Oligonucleotide Synthesis Product and Services
        7.9.4 Gene Oracle Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Gene Oracle Recent Developments/Updates
        7.9.6 Gene Oracle Competitive Strengths & Weaknesses
    7.10 SBS Genetech
        7.10.1 SBS Genetech Details
        7.10.2 SBS Genetech Major Business
        7.10.3 SBS Genetech Solid-phase Oligonucleotide Synthesis Product and Services
        7.10.4 SBS Genetech Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 SBS Genetech Recent Developments/Updates
        7.10.6 SBS Genetech Competitive Strengths & Weaknesses
    7.11 Bio Basic
        7.11.1 Bio Basic Details
        7.11.2 Bio Basic Major Business
        7.11.3 Bio Basic Solid-phase Oligonucleotide Synthesis Product and Services
        7.11.4 Bio Basic Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Bio Basic Recent Developments/Updates
        7.11.6 Bio Basic Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Solid-phase Oligonucleotide Synthesis Industry Chain
    8.2 Solid-phase Oligonucleotide Synthesis Upstream Analysis
    8.3 Solid-phase Oligonucleotide Synthesis Midstream Analysis
    8.4 Solid-phase Oligonucleotide Synthesis Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Solid-phase Oligonucleotide Synthesis Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Solid-phase Oligonucleotide Synthesis Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Solid-phase Oligonucleotide Synthesis Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Solid-phase Oligonucleotide Synthesis Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Solid-phase Oligonucleotide Synthesis Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Solid-phase Oligonucleotide Synthesis Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Solid-phase Oligonucleotide Synthesis Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Solid-phase Oligonucleotide Synthesis Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Solid-phase Oligonucleotide Synthesis Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Solid-phase Oligonucleotide Synthesis Players in 2023
    Table 12. World Solid-phase Oligonucleotide Synthesis Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Solid-phase Oligonucleotide Synthesis Company Evaluation Quadrant
    Table 14. Head Office of Key Solid-phase Oligonucleotide Synthesis Player
    Table 15. Solid-phase Oligonucleotide Synthesis Market: Company Product Type Footprint
    Table 16. Solid-phase Oligonucleotide Synthesis Market: Company Product Application Footprint
    Table 17. Solid-phase Oligonucleotide Synthesis Mergers & Acquisitions Activity
    Table 18. United States VS China Solid-phase Oligonucleotide Synthesis Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Solid-phase Oligonucleotide Synthesis Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Solid-phase Oligonucleotide Synthesis Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Solid-phase Oligonucleotide Synthesis Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Solid-phase Oligonucleotide Synthesis Revenue Market Share (2019-2024)
    Table 23. China Based Solid-phase Oligonucleotide Synthesis Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Solid-phase Oligonucleotide Synthesis Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Solid-phase Oligonucleotide Synthesis Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Solid-phase Oligonucleotide Synthesis Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Solid-phase Oligonucleotide Synthesis Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Solid-phase Oligonucleotide Synthesis Revenue Market Share (2019-2024)
    Table 29. World Solid-phase Oligonucleotide Synthesis Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Solid-phase Oligonucleotide Synthesis Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Solid-phase Oligonucleotide Synthesis Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Solid-phase Oligonucleotide Synthesis Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Solid-phase Oligonucleotide Synthesis Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Solid-phase Oligonucleotide Synthesis Market Size by Application (2025-2030) & (USD Million)
    Table 35. Genescript Basic Information, Area Served and Competitors
    Table 36. Genescript Major Business
    Table 37. Genescript Solid-phase Oligonucleotide Synthesis Product and Services
    Table 38. Genescript Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Genescript Recent Developments/Updates
    Table 40. Genescript Competitive Strengths & Weaknesses
    Table 41. GeneArt (Thermofischer) Basic Information, Area Served and Competitors
    Table 42. GeneArt (Thermofischer) Major Business
    Table 43. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product and Services
    Table 44. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. GeneArt (Thermofischer) Recent Developments/Updates
    Table 46. GeneArt (Thermofischer) Competitive Strengths & Weaknesses
    Table 47. Renesas Electronics Corporation Basic Information, Area Served and Competitors
    Table 48. Renesas Electronics Corporation Major Business
    Table 49. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product and Services
    Table 50. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Renesas Electronics Corporation Recent Developments/Updates
    Table 52. Renesas Electronics Corporation Competitive Strengths & Weaknesses
    Table 53. DNA 2.0 (ATUM) Basic Information, Area Served and Competitors
    Table 54. DNA 2.0 (ATUM) Major Business
    Table 55. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product and Services
    Table 56. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. DNA 2.0 (ATUM) Recent Developments/Updates
    Table 58. DNA 2.0 (ATUM) Competitive Strengths & Weaknesses
    Table 59. OriGene Basic Information, Area Served and Competitors
    Table 60. OriGene Major Business
    Table 61. OriGene Solid-phase Oligonucleotide Synthesis Product and Services
    Table 62. OriGene Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. OriGene Recent Developments/Updates
    Table 64. OriGene Competitive Strengths & Weaknesses
    Table 65. BBI Basic Information, Area Served and Competitors
    Table 66. BBI Major Business
    Table 67. BBI Solid-phase Oligonucleotide Synthesis Product and Services
    Table 68. BBI Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. BBI Recent Developments/Updates
    Table 70. BBI Competitive Strengths & Weaknesses
    Table 71. Genewiz Basic Information, Area Served and Competitors
    Table 72. Genewiz Major Business
    Table 73. Genewiz Solid-phase Oligonucleotide Synthesis Product and Services
    Table 74. Genewiz Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Genewiz Recent Developments/Updates
    Table 76. Genewiz Competitive Strengths & Weaknesses
    Table 77. Eurofins Genomics Basic Information, Area Served and Competitors
    Table 78. Eurofins Genomics Major Business
    Table 79. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product and Services
    Table 80. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Eurofins Genomics Recent Developments/Updates
    Table 82. Eurofins Genomics Competitive Strengths & Weaknesses
    Table 83. Gene Oracle Basic Information, Area Served and Competitors
    Table 84. Gene Oracle Major Business
    Table 85. Gene Oracle Solid-phase Oligonucleotide Synthesis Product and Services
    Table 86. Gene Oracle Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Gene Oracle Recent Developments/Updates
    Table 88. Gene Oracle Competitive Strengths & Weaknesses
    Table 89. SBS Genetech Basic Information, Area Served and Competitors
    Table 90. SBS Genetech Major Business
    Table 91. SBS Genetech Solid-phase Oligonucleotide Synthesis Product and Services
    Table 92. SBS Genetech Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. SBS Genetech Recent Developments/Updates
    Table 94. Bio Basic Basic Information, Area Served and Competitors
    Table 95. Bio Basic Major Business
    Table 96. Bio Basic Solid-phase Oligonucleotide Synthesis Product and Services
    Table 97. Bio Basic Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 98. Global Key Players of Solid-phase Oligonucleotide Synthesis Upstream (Raw Materials)
    Table 99. Solid-phase Oligonucleotide Synthesis Typical Customers
List of Figure
    Figure 1. Solid-phase Oligonucleotide Synthesis Picture
    Figure 2. World Solid-phase Oligonucleotide Synthesis Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Solid-phase Oligonucleotide Synthesis Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Solid-phase Oligonucleotide Synthesis Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Solid-phase Oligonucleotide Synthesis Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Solid-phase Oligonucleotide Synthesis Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Solid-phase Oligonucleotide Synthesis Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Solid-phase Oligonucleotide Synthesis Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Solid-phase Oligonucleotide Synthesis Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Solid-phase Oligonucleotide Synthesis Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Solid-phase Oligonucleotide Synthesis Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Solid-phase Oligonucleotide Synthesis Revenue (2019-2030) & (USD Million)
    Figure 13. Solid-phase Oligonucleotide Synthesis Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Solid-phase Oligonucleotide Synthesis Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Solid-phase Oligonucleotide Synthesis Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Solid-phase Oligonucleotide Synthesis Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Solid-phase Oligonucleotide Synthesis Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Solid-phase Oligonucleotide Synthesis Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Solid-phase Oligonucleotide Synthesis Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Solid-phase Oligonucleotide Synthesis Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Solid-phase Oligonucleotide Synthesis Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Solid-phase Oligonucleotide Synthesis Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Solid-phase Oligonucleotide Synthesis by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Solid-phase Oligonucleotide Synthesis Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Solid-phase Oligonucleotide Synthesis Markets in 2023
    Figure 27. United States VS China: Solid-phase Oligonucleotide Synthesis Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Solid-phase Oligonucleotide Synthesis Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Solid-phase Oligonucleotide Synthesis Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type in 2023
    Figure 31. Primers
    Figure 32. Probes
    Figure 33. Intermediate-scale Synthesis Oligos
    Figure 34. Large-scale Synthesis Oligos
    Figure 35. Linkers and Adaptors
    Figure 36. World Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type (2019-2030)
    Figure 37. World Solid-phase Oligonucleotide Synthesis Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 38. World Solid-phase Oligonucleotide Synthesis Market Size Market Share by Application in 2023
    Figure 39. Commercial
    Figure 40. Academic Research
    Figure 41. Solid-phase Oligonucleotide Synthesis Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Genescript
GeneArt (Thermofischer)
Renesas Electronics Corporation
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic

Related Reports

Global Solid-phase Oligonucleotide Synthesis Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Solid-phase Oligonucleotide Synthesis Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 01 Sep 2023

date Medical Care

According to our (Global Info Research) latest study, the global Solid-phase Oligonucleotide Synthesis market size was valued at USD 433.2 million in 2022 and is forecast to a readjusted size of USD 1230 million by 2029 with a CAGR of 16.1% during review period.

Global Solid-phase Oligonucleotide Synthesis Supply, Demand and Key Producers, 2023-2029

Global Solid-phase Oligonucleotide Synthesis Supply, Demand and Key Producers, 2023-2029

date 01 Sep 2023

date Medical Care

The global Solid-phase Oligonucleotide Synthesis market size is expected to reach $ 1230 million by 2029, rising at a market growth of 16.1% CAGR during the forecast period (2023-2029).

Global Solid-phase Oligonucleotide Synthesis Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Solid-phase Oligonucleotide Synthesis Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Solid-phase Oligonucleotide Synthesis market size was valued at USD 433.2 million in 2023 and is forecast to a readjusted size of USD 1230 million by 2030 with a CAGR of 16.1% during review period.

Product Tags

Solid-phase Oligonucleotide Synthesis

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>